CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
CD19 CAR T-cell therapy had expected toxic effects and resulted in sustained remission in patients with multirefractory AIHA. (Funded by the National Key Research and Development Program of China and others; ClinicalTrials.gov number, NCT06231368.).
Authors
- Wang Wc
- Pan Xp
- Jingyu Zhao (ORCID: https://orcid.org/0000-0001-5744-3097)
- Chunqiang Xu (ORCID: https://orcid.org/0000-0002-2564-2689)
- Yizhou Zheng (ORCID: https://orcid.org/0000-0002-8246-5009)
- J F Shi
- Linzhu Tian
- Lele Zhang
- Haiqing Xiong (ORCID: https://orcid.org/0000-0002-1260-2426)
- Weiwang Li
- Y. Liu
- Guangxin Peng
- J. Li
- Yi Feng
- Fei Yang (ORCID: https://orcid.org/0000-0002-2768-5949)
- Ruonan LI
- Huang Jb
- Shuo Chen (ORCID: https://orcid.org/0000-0002-4457-3922)
- Lian Yu
- Xingxin Li
- Zhen Gao
- Lei Fang (ORCID: https://orcid.org/0000-0001-9980-8285)
- Xiaojuan Yu (ORCID: https://orcid.org/0000-0003-4600-7841)
- X M Zhao
- Min Dai (ORCID: https://orcid.org/0000-0002-0099-4725)
- Yuechen Luo
- Yucan Shen (ORCID: https://orcid.org/0009-0002-9147-9039)
- Zhexiang Kuang
- Jiaxiu Ma
- Neng Nie
- Biping Deng
- Lijun Liu
- Lulu Lv
- Alex H. Chang
- Liyun Li
- Hong Pan
- Meili Ge
- Lifang Huang
Institutions
- Shanxi Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fudan University (CN)
- Beijing United Family Hospital (CN)
- Shanghai CASB Biotechnology (China) (CN)
- Nanfang Hospital (CN)
- Ministry of Education (KR)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Shanghai Cell Therapy Research Institute (CN)
- Shanxi Academy of Medical Sciences (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1056/nejmoa2509820
- Citations
- 3
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 72.59